Nitric Oxide Mediates IL-1β Stimulation of Heat Shock Protein but Not IL-1β Inhibition of Glutamic Acid Decarboxylase

References

• Eisenbarth G. S. Type I diabetes mellitus: a chronic autoimmune disease. N. Engl. J. Med. 1986; 314: 1360–8
   PubMed Web of Science ®Google Scholar
• Hao W., Maclaren N. K. Prediction and prevention of insulin-dependent diabetes. Perspectives in General Surgery, B. A. Levine. Quality Medical Publishing, St Louis, MO 1991; Vol. 2: 113–30
   Google Scholar
• Palmer J. P., McCulloch D. K. Perspectives in diabetes: prediction and prevention of IDDM. Diabetes 1991; 40: 943–7
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T., Bendtzen K., Nerup J., Dinarello C. A., Svenson M., Nelsen J. H. Affinity-purified human interleukin-1 is cytotoxic to isolated islets of Langerhans. Diabetologia 1986; 29: 63–7
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T., Bendtzen K., Dinarello C. A., Nerup J. Human necrosis factor potentiates human interleukin-1 mediated rat pancreatic beta-cell cytotoxicity. J. Immunol. 1987; 139: 4077–82
   PubMed Web of Science ®Google Scholar
• Helqvist S., Polla B. S., Johannesen J., Nerup J. Heat shock protein induction in rat pancreatic islets by recombinant human interleukin-1β. Diabetologia 1991; 34: 150–6
   PubMed Web of Science ®Google Scholar
• Spinas G. A., Palmer J. P., Mandrup-Poulsen T., Anderson H., Nielsen J. H., Nerup J. The bimodal effect of interleukin-1 on rat pancreatic beta-cells-stimulation followed by inhibition-depends on dose, duration of exposure, and ambient glucose concentration. Acta Endocrinol. 1988; 119: 307–11
   PubMedGoogle Scholar
• Mehta V. K., Hao W., Brooks-Worrell B. M., Palmer J. P. Low-dose interleukin-1 and tumor necrosis factor individually stimulate insulin release but in combination cause suppression. Eur. J. Endocrinol. 1994; 130: 208–14
   PubMed Web of Science ®Google Scholar
• Mehta V. K., Hao W., Brooks-Worrell B. M., Palmer J. P. The functional state of the beta cell modulates IL-1 and TNF-induced cytotoxicity. Lymphokine Cytokine Res. 1993; 12: 255–9
   PubMedGoogle Scholar
• Palmer J. P., Helqvist S., Spinas G. A., Molvig J., Mandrup-Poulsen T., Andersson H. U., et al. Interaction of β-cell activity and IL-1 concentration and exposure time in isolated rat islets of Langerhans. Diabetes 1989; 38: 1211–16
   PubMed Web of Science ®Google Scholar
• Hao W., Palmer J. P. The effect of cytokines on expression of glutamic acid decarboxylase-65 in cultured islets. Autoimmunity 1995; 22: 209–18
   PubMed Web of Science ®Google Scholar
• Hao W., Palmer J. P. Recombinant human transforming growth factor βdoes not inhibit the effects of interleukin-β on pancreatic islet cells. J. Interferon & Cytokine Res. 1995; 15: 1075–81
   PubMed Web of Science ®Google Scholar
• Southern C., Schulster D., Green I. C. Inhibition of insulin secretion by interleukin-β and tumor necrosis factor-α via an L-argininc-dependent nitric oxide generating mechanism. FEBS Lett. 1990; 276: 42–4
   PubMed Web of Science ®Google Scholar
• Corbett J. A., Wang J. L., Hughes J. H., Wolf B. A., Sweetland M. A., Lancaster J. R., et al. Nitric oxide and cyclic GMP formation induced by interleukine 1β in islets of Langerhans. Biochem. J. 1992; 287: 229–35
   PubMed Web of Science ®Google Scholar
• Corbett J. A., Wang J. L., Sweetland M. A., Lancaster J. R., Jr., McDaniel M. L. Interleukin 1β induces the formation of nitric oxide by β-cells purified from rodent islets of Langerhans: Evidence for the β-cell as a source and site of action of nitric oxide. J. Clin. Invest. 1992; 90: 2384–91
   PubMed Web of Science ®Google Scholar
• Corbett J. A., Sweetland M. A., Lancaster J. R., Jr., McDaniel M. L. A 1-hour pulse with IL-1β induces formation of nitric oxide and inhibits insulin secretion by rat islets of Langerhans: Evidence for a tyrosinc kinase signaling mechanism. FASEB J. 1993; 7: 369–74
   PubMed Web of Science ®Google Scholar
• Bergmann L., Kroncke K. D., Suschek C., Kolb H., Kolb-Bachofern V. Cytotoxic action of IL-1β against pancreatic islets is mediated via nitric oxide formation and is inhibited by NG-monomethyl-L-arginine. FEBS Lett. 1992; 299: 103–6
   PubMed Web of Science ®Google Scholar
• Corbett J. A., McDaniel M. L. Reversibility of interleukin-1β-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase. Biochem. J. 1994; 299: 719–24
   PubMed Web of Science ®Google Scholar
• Welsh N., Eizirik D. L., Bendtzen K., Sandier S. Interlcukin-1β induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 1991; 129: 3167–73
   PubMed Web of Science ®Google Scholar
• Delaney C. A., Green M. H.L., Lowe J. E., Green I. C. Endogenous nitric oxide induced by interleukin-1β in rat islets of Langerhans and HIT-T15 cells causes significant DNA damage as measured by the “cometi” assay. FEBS Lett. 1993; 333: 291–5
   PubMed Web of Science ®Google Scholar
• Fehsel K., Jalowy A., Qi S., Burkart V., Hartmann B., Kolb H. Islet cell DNA is a target of inflammatory attack by nitric oxide. Diabetes 1993; 42: 496–500
   PubMed Web of Science ®Google Scholar
• Heller B., Wang Z. Q., Wagner E. F., Radous J., Burkle A., Fehsel K., et al. Inactivation of the poly(ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells. J. Biol. Chem. 1995; 270: 11176–80
   PubMed Web of Science ®Google Scholar
• Ankarcrona M., Dypbukt J. M., Brune B., Nicotera P. Interlcukin-1β-induced nitric oxide production activates apoptosisin pancreatic RINm5F cells. Exp. Cell. Res. 1994; 213: 172–7
   PubMed Web of Science ®Google Scholar
• Kaneto H., Fujii J., Sco H. G., Suzuki K., Matsuoka T. A., Nakamura M., et al. Apoptotic cell death triggered by nitric oxide in pancreatic β-cells. Diabetes 1995; 44: 733–8
   PubMed Web of Science ®Google Scholar
• Brunstedt J., Nielsen J. H., Lernmark A., Hagedorn Study Group. Isolation of islets from mice and rats. Methods in Diabetes Research: Laboratory Methods, J. Lasner, S. L. Phol. John Wiley and Sons, New York 1984; 254–8
   Google Scholar
• Lowenstein C. J., Snyder S. H. Nitric oxide, a novel biological messenger. Cell 1992; 70: 705–7
   PubMed Web of Science ®Google Scholar
• Marietta M. A. Nitric oxide synthase structure and mechanism. J. Biol. Chem. 1993; 268: 12231–4
   PubMed Web of Science ®Google Scholar
• Lamas S., Marsden P. A., Li G. K., Tempst P., Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc. Natl. Acad. Sci. USA 1992; 89: 6348–52
   PubMed Web of Science ®Google Scholar
• Bredt D. S., Hwang P. M., Glatt C. E., Lowenstein C., Reed R. R., Snyder S. H. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991; 351: 714–18
   PubMed Web of Science ®Google Scholar
• Xie Q., Cho H. J., Calaycay J., Mumford R. A., Swiderek K. M., Lee T. D., et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992; 256: 225–8
   PubMed Web of Science ®Google Scholar
• Corbett J. A., Sweetland M. A., Wang J. L., Lancaster J. R., Jr., McDaniel M. L. Nitric oxide mediated cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc. Natl. Acad. Sci. USA 1993; 90: 1731–5
   PubMed Web of Science ®Google Scholar
• Dimmeler S., Ankarcrona M., Nicotera P., Brune B. Exogenous nitric oxide (NO) generation or IL-1β induced intracellular NO production stimulates inhibitory auto- ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase in RINm5F cells. J. Immunol. 1993; 150: 2964–71
   PubMed Web of Science ®Google Scholar
• Eizirik D. L., Cagliero E., Bjorklund A., Welsh N. Interleukin-1β induces the expression of an isoform of nitric oxide synthase in insulin-producing cells, which is similar to that observed in activated macrophages. FEBS Lett. 1992; 308: 249–52
   PubMed Web of Science ®Google Scholar
• Corbett J. A., Kwon G., Misko T. P., Rodi C. P., McDaniel M. L. Tyrosine kinase involvement in IL-1β- induced expression of iNOS by β-cells purified from islets of Langerhans. Am. J. Physiol. 1994; 267: C48–C54
   Google Scholar
• Karlsen A. E., Andersen H. U., Vissing H., Larsen P. M., Fey S. J., Cuantero B. G., et al. Cloning and expression of cytokine-inducible nitric oxide synthase cDNA from rat islets of Langrhans. Diabetes 1995; 44: 753–8
   PubMed Web of Science ®Google Scholar
• Kleemann R., Rothe H., Kolb-Bachofen V., Xie Q. W., Nathan C., Martin S., et al. Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats. FEBS Lett. 1993; 328: 9–12
   PubMed Web of Science ®Google Scholar
• Andersen H. U., Jorgensen K. H., Egeberg J., Mandrup-Poulsen T., Nerup J. Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans. Diabetes 1994; 43: 770–7
   PubMed Web of Science ®Google Scholar
• Eizirik D. L., Sandier S., Welsh N., Cetkovic-Cvrljc M., Nieman A., Geller D. A., et al. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J. Clin. Invest. 1994; 93: 1968–74
   PubMed Web of Science ®Google Scholar
• Rabinovitch A., Suarez-Pinzon W. L., Strynadka K., Schulz R., Lakey J. R.T., Warnock G. L., et al. Human pancreatic islet β-cell destruction by cytokines is independent of nitric oxide production. J. Clin. Endocrinol. Metab. 1994; 79: 1058–62
   PubMed Web of Science ®Google Scholar
• Kroncke K. D., Rodriguez M. L., Kolb H., Kolb-Bachofen V. Cytotoxicity of activated rat macrophages against syngenic islet cells is arginine-dependent, correlates with citrulline and nitrite concentrations and is identical to lysis by the nitric oxide donor nitroprusside. Diabetologia 1993; 36: 17–24
   PubMed Web of Science ®Google Scholar
• Cetkovic-Cvrljc M., Sandier S., Eizirik D. L. Nicotinamide and dcxamethasone inhibit interleukin-1 induced nitric oxide production by RINm5F cells without decreasing messenger ribonucleic acid expression for nitric oxide synthase. Endocrinology 1993; 133: 1739–43
   PubMed Web of Science ®Google Scholar
• Delaney C. A., Eizirik D. L., Lowe J. E., et al. Effects of nitric oxide on DNA damage and ultrastructure in islets of Langerhans-a comparison of human and rodent. Diabetologia 1995; 38(Suppl. 1)A17, (Abstract)
   Google Scholar
• Velloso L. A., Bjork E., Ballagi A. E., Funa K., Andersson A., et al. Regulation of GAD expression in islets of Langerhans occurs both at the mRNA and protein level. Molecular and Cellular Endocrinol. 1994; 102: 31–7
   PubMed Web of Science ®Google Scholar
• Schmidli R. S., Faulkner-Jones B. E., Harrison L. C., James R. F.L., Deaizpurua H. J. Cytokine regulation of glutamate decarboxylase biosynthesis in isolated rat islets of Langerhans. Biochem. J. 1996; 317: 713–19
   PubMed Web of Science ®Google Scholar
• Rothe H., Faust A., Schade U., Kleemann R., Bosse G., Hibino T., et al. Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4. Diabetologia 1994; 37: 1154–8
   PubMed Web of Science ®Google Scholar
• Reimers J. I., Andersen H. U., Mauricio D., Pociot F., Karlsen A. E., Pctersen J. S., et al. Strain-dependent differences in sensitivity of rat beta-cells to IL-1β in vitro and in vivo: Association with islet nitric oxide synthase. Diabetes 1996; 45: 771–8
   PubMed Web of Science ®Google Scholar
• Reimers J. I., Bjerre Li., Mandrup-Poulsen T., Nerup J. Intelukin-1β induces diabetes and fever in normal rats by nitric oxide via induction of different nitric oxide synthase. Cytokine 1994; 6: 512–20
   PubMed Web of Science ®Google Scholar
• Lukic M. L., Stosic-Grujicic S., Ostojic N., Chan W. L., Liew F. Y. Inhibition of nitric oxide generation affects the induction of diabetes by streptozocin in mice. Biochem. Biophys. Res. Commun. 1991; 178: 913–20
   PubMed Web of Science ®Google Scholar
• Corbett J. A., Mikheal A., Shimizu J., Frederick K., Misko T. P., McDaniel M. L., et al. Nitric oxide production in islets form nonobese diabetic mice: Aminoguanidine- sensitive and -resistant stages in the immunological diabetic process. Proc. Natl. Acad. Sci. USA 1993; 90: 8992–5
   PubMed Web of Science ®Google Scholar
• Lindsay R. M., Smith W., Rossiter S. P., Mclntyre M. A., Williams B. C., Baird J. D. NG-nitro-L-arginine methy-lester reduces the incidence of IDDM in BB/E rats. Diabetes 1995; 44: 365–8
   PubMed Web of Science ®Google Scholar
• Welsh M., Welsh N., Bendtzen K., Mares J., Strandell E., Oberg C., et al. Comparison of mRNA contents of interleukin-1β and nitric oxide synthase in pancreatic islets isolated from female and male nonobese diabetic mice. Diabetologia 1995; 38: 153–60
   PubMed Web of Science ®Google Scholar
• Sumoski W., Baquerizo H., Rabinovitch A. Oxygen free radical scavengers protect rat islet cells from damage by cytokines. Diabetologia 1989; 32: 792–6
   PubMed Web of Science ®Google Scholar
• Nerup J., Mandrup-Poulsen T., Molvig J., Helqvist S., Wogensen L., Egeberg J. Mechanisms of pancreatic β-cell destruction in type 1 diabetes. Diabetes Care 1988; 11(Suppl. I)16–23
   PubMedGoogle Scholar
• Corbett J. A., Kwon G., Turk J., McDaniel M. L. IL-1β induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: Activation of cyclooxygenase by nitric oxide. Biochemistry 1993; 32: 13767–70
   PubMed Web of Science ®Google Scholar